Skip to content
CancerIndex

Publication

Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.

Authors not recorded

Nat Genet2014PMID 24658004PMC5699446stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (5)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 5

Curated evidence

Evidence citing this paper (2)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
24658004
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–2 of 2 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
SMARCA4 INACTIVATING MUTATION1
(prognostic)Lung AdenocarcinomaPrognosticBSupports Poor Outcome4accepted
EID513

In patients with lung adenocarcinoma, those with loss-of-function mutations in SMARCA4 had worse overall survival than those with only missense or no mutations.

PMID 24658004 · Jelinic et al., 2014 · Open in CIViC

civic
SMARCA4 Mutation1
(diagnostic)Small-cell Carcinoma Of The Ovary Of Hypercalcemic TypeUNRESOLVEDDiagnosticBSupports Positive5accepted
EID512

Nonsense mutations in SMARCA4 were associated with small cell carcinoma of the ovary, hypercalcemic type in 10/10 tumor samples, and were rarely found in other solid tumor types catalogued by TCGA.

PMID 24658004 · Jelinic et al., 2014 · Open in CIViC

civic